Navigation Links
FDA Principal Deputy Commissioner Joins Keynote Line-Up for the 2019 ISPE Annual Meeting & Expo
Date:10/10/2019

The International Society for Pharmaceutical Engineering (ISPE) announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo, taking place 27–30 October 2019 in Las Vegas, Nevada USA.

Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data expert and clinical researcher. She helps oversee the FDA’s day-to-day functioning and directs special and high-priority initiatives that cut across offices overseeing the agency's regulation of drugs, medical devices, tobacco, and food. As acting Chief Information Officer, she oversees FDA’s data and technical vision, and its execution.

In a “fireside chat” with Frances Zipp, President & CEO, Lachman Consultant Services, Inc., incoming 2019–2020 ISPE Board Chair, Dr. Abernethy will be answering key questions regarding current FDA initiatives.

Dr. Abernethy joins a dynamic keynote line-up that includes some of the most prominent names in the pharmaceutical industry. These senior-level presentations are rounded out by a compelling patient keynote speaker.

Additional Keynote Presenters Include:

Lou Kennedy, CEO and Owner, Nephron Pharmaceuticals
Training Tomorrow’s Workforce

John Crowley, Chairman, Chief Executive Officer, and Co-Founder Amicus Therapeutics
When Drug Research is Personal: A Lifetime Journey to Discover, Create and Manufacture Medicines for Rare Diseases

William Anderson, Chief Executive Officer, Roche Pharmaceuticals
Every Patient Matters — Transforming to Deliver Breakthroughs Faster

Pierre-Alain Ruffieux, PhD, Head of Global Pharma Technical Operations, Roche Pharmaceuticals
Transforming Big Pharma Manufacturing: Dream or Reality?

Alberto Santagostino, Senior Vice President, Head of Cell & Gene Technologies, Lonza AG
How to Achieve Industrialization and Bring Curative Therapies to the Masses

Jessica H., Patient Presenter
Thriving in My New Normal

To learn more about this event and to register, visit http://www.ISPE.org/AM19.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Amy Henry
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1- 813-960-2105 Ext. 277
Email: ahenry@ispe.org
http://www.ISPE.org

Read the full story at https://www.prweb.com/releases/fda_principal_deputy_commissioner_joins_keynote_line_up_for_the_2019_ispe_annual_meeting_expo/prweb16630963.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Jackson Hole Group, LLC Welcomes Marnie McBryde as a New Principal
2. Tunnell Consulting Names John S. Ross as Principal, Life Sciences
3. First Warning Systems, Inc., Retains Joshua D.I. Ellenhorn, M.D., as Principal Investigator
4. IDC MarketScape annovera la soluzione cloud-based di Veeva tra le principali soluzioni CRM dedicate alle scienze della vita
5. Rich Pharmaceuticals, Inc. Names Chittima Sirijerachai, MD as Principal Investigator for Upcoming AML Clinical Trials
6. Modality Solutions Names Judy Tempel Principal Consulting Engineer
7. National Association of Professional Women Inducts Patricia Sparrell, Principal, PTSparrell Consulting, Into its VIP Professional Woman of the Year Circle
8. Benchmark Research announces the promotion of two long-standing Principal Investigators.
9. Cold Chain Technologies Promotes Richard Formato to Principal Technologist
10. U.S. Department of Health and Human Services Deputy Secretary to Present Keynote Address at Conference Hosted by DIA and NORD
11. Noted Epidemiologist and Former FDA Deputy Director Janet B. Arrowsmith, MD, Joins NDA Partners as a Premier Expert Consultant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):